Angewandte
Chemie
Weigel in Chirality in Industry II (Eds.: A. N. Collins, A. N.
[
1] a) J. Wu, J.-XJi, R. Guo, C.-H. Yeung, A. S. C. Chan, Chem. Eur.
J. 2003, 9, 2963 – 2968; b) M. Scalone, P. Waldmeier, Org. Process
Res. Dev. 2003, 7, 418 – 425; c) M. J. Burk, W. Hems, D.
Herzberg, C. Malan, A. Zanotti-Gerosa, Org. Lett. 2000, 2,
Sheldrake, J. Crosby), Wiley, Chichester, 1997, chap. 6.
[11] T. Ohkuma, M. Koizumi, M. Yoshida, R. Noyori, Org. Lett. 2000,
2, 1749 – 1751.
[12] The Supporting Information includes the procedures for prepar-
ing the precatalyst and conducting the asymmetric hydrogena-
tion, and detailed analytical methods for determining the ee
values.
4173 – 4176; d) D. Chaplin, P. Harrison, J. P. Henschke, I. C.
Lennon, G. Meek, P. Moran, C. J. Pilkington, J. A. Ramsden, S.
Watkins, A. Zanotti-Gerosa, Org. Process Res. Dev. 2003, 7, 89 –
9
4; e) J. P. Henschke, A. Zanotti-Gerosa, P. Moran, P. Harrison,
B. Mullen, G. Casy, I. C. Lennon, Tetrahedron Lett. 2003, 44,
379 – 4383; f) J. Wu, H. Chen, W. Kwok, R. Guo, Z. Zhou, C.
4
Yeung, A. S. C. Chan, J. Org. Chem. 2002, 67, 7908 – 7910; h) J.-
H. Xie, L.-X. Wang, Y. Fu, S.-F. Zhu, B.-M. Fan, H.-F. Duan, Q.-
L. Zhou, J. Am. Chem. Soc. 2003, 125, 4404 – 4405.
[
2] a) R. Noyori, T. Ohkuma, Angew. Chem. 2001, 113, 41 – 75;
Angew. Chem. Int. Ed. 2001, 40, 40 – 73, and references therein;
b) R. Noyori, Angew. Chem. 2002, 114, 2108 – 2123; Angew.
Chem. Int. Ed. 2002, 41, 2008 – 2022, and references therein.
Xylbinap = 2,2’-bis(di-3,5-xylylphosphanyl)-
1,1’-binaphthyl,
daipen = 1,1-di-4-anisyl-2-isopropyl-1,2-ethylenediamine.
3] a) R. Hartmann, P. Chan, Angew. Chem. 2001, 113, 3693 – 3697;
Angew. Chem. Int. Ed. 2001, 40, 3581 – 3585; b) C. A. Sandoval,
T. Ohkuma, K. Muniz, R. Noyori, J. Am. Chem. Soc. 2003, 125,
[
13490 – 13503; c) K. Abdur-Rashid, M. Faatz, A. J. Lough, R. H.
Morris, J. Am. Chem. Soc. 2001, 123, 7473 – 7474.
[
4] a) G. Zhu, P. Cao, Q. Jiang, X. Zhang, J. Am. Chem. Soc. 1997,
119, 1799 – 1800; b) P. Cao, X. Zhang, J. Org. Chem. 1999, 64,
2127 – 2129; c) X. Zhang (The Pennsylvania State University),
WO 9924443, 1999.
[
5] The route involves an enzymatic kinetic resolution that gives
both (1R,1’R)-dicyclopentane-(2S,2’S)-diol and (1S,1’S)-dicyclo-
pentane-(2R,2’R)-diol. Each of the two chiral diols is converted
to the corresponding bis(benzenesulfonate). Subsequent reac-
tion with NaPAr (BH ) and deprotection of the bis(borane)
2
3
adduct affords 1. The new procedure allows the large-scale
synthesis of diphospanes 1 and will be reported in due course.
6] a) C. E. Tucker, Q. Jiang (DSM N.V.), US 2003181319, 2003;
b) C. E. Tucker, Q. Jiang (DSM N. V.), US 2003181318, 2003;
c) C. E. Tucker, Q. Jiang (DSM N.V.), US 2003171213, 2003;
d) C. E. Tucker, Q. Jiang (DSM N.V.), WO 2003061826, 2003;
e) C. E. Tucker, Q. Jiang (DSM N.V.), WO 2003061825, 2003;
f) C. E. Tucker, Q. Jiang (DSM N.V.), WO 2003061824, 2003.
7] a) S. Borman, Chem. Eng. News 2003, 81, 29 – 31; b) W. Leong,
M. Chen, B. A. D'Sa, M. Zhu, T. Xiao, X. Shi, S. Tang, D. Gala,
A. J. Goodman, C. M. Nielsen, G. M. Lee, J. A. Gamboa, A. D.
Jones (Schering-Plough Corporation, US), WO 03/084950, 2003;
c) B. M. Baroudy, J. W. Clader, H. B. Josien, S. W. McCombie,
B. A. McKittrick, M. W. Miller, B. R. Neustadt, A. Palani, E. M.
Smith, R. Steensma, J. R. Tagat, S. F. Vice, M. A. Laughlin, E.
Gilbert, M. A. Labroli (Schering-Plough Corporation, US), WO
[
[
00/66558, 2000.
[
8] H. Harada, Y. Hirokawa, K. Suzuki, Y. Hiyama, M. Oue, H.
Kawashima, N. Yoshida, Y. Furutani, S. Kato, Bioorg. Med.
Chem. Lett. 2003, 13, 1301 – 1305.
[
9] a) K. .M. J. Brands, J. F. Payack, J. D. Rosen, T. D. Nelson, A.
Candelario, M. A. Huffman, M. M. Zhao, J. Li, B. Craig, Z. J.
Song, D. M. Tschaen, K. Hansen, P. N. Devine, P. J. Pye, K.
Rossen, P. G. Dormer, R. A. Reamer, C. J. Welch, D. J. Mathre,
N. N. Tsou, J. M. McNamara, P. J. Reider, J. Am. Chem. Soc.
2003, 125, 2129 – 2135; b) G. A. Reichard, C. Stengone, S.
Paliwal, I. Mergelsberg, S. Majmundar, C. Wang, R. Tiberi,
A. T. McPhail, J. J. Piwinski, N.-Y. Shih, Org. Lett. 2003, 5, 4249 –
4251.
[
10] a) R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner,
H.-Y. Kuan, M. P. Knadler, Drug Metab. Dispos. 2003, 31, 1142 –
1150; b) J. Deeter, J. Frazier, G. Staten, M. Staznak, L. Weigel,
Tetrahedron Lett. 1990, 31, 7101 – 7104; c) B. A. Astleford, L. O.
Angew. Chem. Int. Ed. 2004, 43, 2816 –2819
ꢀ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2819